{
  "id": 168181,
  "name": "GENENTECH, INC.",
  "slug": "genentech-inc",
  "state": "CA",
  "description": "pharmaceutical and biotechnology company",
  "totalSpending": 1400000,
  "filings": 28,
  "yearlySpending": [
    {
      "year": 2018,
      "income": 150000
    },
    {
      "year": 2019,
      "income": 200000
    },
    {
      "year": 2020,
      "income": 200000
    },
    {
      "year": 2021,
      "income": 200000
    },
    {
      "year": 2022,
      "income": 150000
    },
    {
      "year": 2023,
      "income": 200000
    },
    {
      "year": 2024,
      "income": 100000
    },
    {
      "year": 2025,
      "income": 200000
    }
  ],
  "firms": [
    "CORNERSTONE GOVERNMENT AFFAIRS, INC."
  ],
  "lobbyists": [
    "MICHAEL SMITH",
    "MARK MIODUSKI",
    "LAURA BOZELL",
    "ERIK FATEMI",
    "CHRISTOPHER SARLEY",
    "TONY ESSALIH",
    "WILLIAM SMITH",
    "MICHAEL GOODMAN"
  ],
  "issues": [
    "HCR",
    "BUD",
    null
  ],
  "sampleDescriptions": [
    "Reauthorization of the Pandemic and All-Hazards Preparedness Act and appropriations relating to influenza.",
    "Appropriations relating to influenza",
    "Appropriations relating to influenza.",
    "Appropriations relating to pandemic influenza."
  ],
  "years": [
    2018,
    2019,
    2020,
    2021,
    2022,
    2023,
    2024,
    2025
  ],
  "growthRate": 33,
  "trajectory": "growing",
  "yearsActive": 8,
  "avgAnnualSpending": 175000,
  "peakYear": 2019,
  "lobbyistCount": 8,
  "firmCount": 1,
  "issueCount": 2,
  "industry": "technology"
}